Ad Scientiam Launches International Study to Assess Disability Progression in multiple sclerosis with MSCopilot®

Ad Scientiam Launches International Study to Assess Disability Progression in multiple sclerosis with MSCopilot®Paris, 12 September, 2023 – Ad Scientiam, a global leader in digital biomarkers has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-...

Related Keywords

France ,Italy ,Spain ,Denmark ,Germany ,Canada ,Paris ,France General ,United States ,America ,Saad Zina ,Novartis ,Study Steering Committee ,Instagram ,Facebook ,Paris Brain Institute ,Pfizer ,Linkedin ,Global Head Of Medical Affairs ,Assess Disability Progression ,Expanded Disability Status Scale ,Multiple Sclerosis Functional Composite ,Chief Medical Officer ,Global Head ,Medical Affairs ,Patrick Vermersch ,Coordinating Investigator ,Study Steering ,North America ,Quality Management System ,